Risk of delirium with concomitant use of tolterodine and acetaicholinesterase inhibitors

被引:41
作者
Edwards, KR [1 ]
O'Connor, JT [1 ]
机构
[1] Alzheimers Diagnost & Treatment Ctr, Bennington, VT 05201 USA
关键词
D O I
10.1046/j.1532-5415.2002.50281.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:1165 / 1166
页数:2
相关论文
共 5 条
[1]   Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder [J].
Drutz H.P. ;
Appell R.A. ;
Gleason D. ;
Klimberg I. ;
Radomski S. .
International Urogynecology Journal, 1999, 10 (5) :283-289
[2]   Tolterodine: A safe and effective treatment for older patients with overactive bladder [J].
Malone-Lee, JG ;
Walsh, JB ;
Maugourd, MF .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (06) :700-705
[3]   Drug-induced cognitive impairment in the elderly [J].
Moore, AR ;
O'Keeffe, ST .
DRUGS & AGING, 1999, 15 (01) :15-28
[4]   DISRUPTION OF HUMAN EYEBLINK CONDITIONING AFTER CENTRAL CHOLINERGIC BLOCKADE WITH SCOPOLAMINE [J].
SOLOMON, PR ;
GROCCIAELLISON, M ;
FLYNN, D ;
MIRAK, J ;
EDWARDS, KR ;
DUNEHEW, A ;
STANTON, ME .
BEHAVIORAL NEUROSCIENCE, 1993, 107 (02) :271-279
[5]  
WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341